Home » Archive

Marketwire

Marketwire, News, Syndication »

Quidel to Present at 24th Annual Piper Jaffray Healthcare Conference

Posted by sandiegobiotech November 20th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Nov 20, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions and cellular-based virology assays, announced today that it will present at the 24th Annual Piper Jaffray Healthcare C…

More...

Marketwire, News, Syndication »

Urologic Surgery Pioneer Dr. Alexander Gershman Joins Medistem’s Scientific Advisory Board

Posted by sandiegobiotech November 19th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Nov 19, 2012) – Medistem (PINKSHEETS: MEDS) announced today appointment of Alexander Gershman, MD, Ph.D to the company’s Scientific Advisory Board. Dr. Gershman is an internationally-renowned opinion leader in urologica…

More...

Marketwire, News, Syndication, Top News »

Cytori to Webcast Second Quarter Financial Results on August 8

Posted by sandiegobiotech July 26th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 26, 2012) – Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Wednesday, August 8, 2012 at 5:00 PM Eastern Time.
The dial-in informa…

More...

Marketwire, News, Syndication »

Cytori to Webcast Second Quarter Financial Results on August 8

Posted by Mary Canady July 26th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 26, 2012) – Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Wednesday, August 8, 2012 at 5:00 PM Eastern Time.
The dial-in informa…

More...

Marketwire, News, Syndication, Top News »

Quidel Reports Second Quarter 2012 Financial Results

Posted by sandiegobiotech July 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 25, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, announced today financial results for the second quarter ended June 30, 2012…

More...

Marketwire, News, Syndication, Top News »

Aegis Awarded Patent for Monoclonal Antibody Formulations That Avoid Oxidative Damage Due to Polysorbate Surfactants

Posted by sandiegobiotech July 24th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 24, 2012) –  Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,226,949 providing broad protection for stabilized formulations of monoclonal antibodies. The Aegis ProTek® excipients p…

More...

Marketwire, News, Syndication »

Medistem Launches Critical Limb Ischemia Clinical Trial

Posted by Mary Canady July 13th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 13, 2012) – Medistem Inc. (PINKSHEETS: MEDS) and the Chinese Conglomerate, Shanghai Jia Fu Medical Apparatus Inc, announced today successful administration of Medistem’s Endometrial Regenerative Cell (ERC) universal …

More...

Marketwire, News, Syndication »

Medistem to Give Keynote Address at International Gathering of Romanian Leaders

Posted by Mary Canady July 12th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 12, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced today it has been chosen by the Romanian Cultural Association to give a keynote talk at its annual gathering in Hamilton, Canada.
The meeting, which is a…

More...

Marketwire, News, Syndication »

Quidel to Hold Second Quarter 2012 Financial Results Conference Call on July 25, 2012

Posted by Mary Canady July 10th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 10, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release second quarter 2012 financial results after market close on Wed…

More...

Marketwire, News, Syndication »

Medistem Receives Notice of Patent Allowance Covering Fat Stem Cell Therapy of Autoimmune Diseases

Posted by Mary Canady June 28th, 2012 .
No Comments

SAN DIEGO CA–(Marketwire – Jun 29, 2012) –  Medistem Inc. (PINKSHEETS: MEDS) announced today notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the use of fat stem cells, and cells associated with f…

More...